IFIT3 appears to act as a pro-oncogene in some cancers, such as HNSCC/OSCC [16,68]; pancreatic cancer [69] and CRC (by promoting cell viability and migration) [70]. This evidence concerns the gene IFIT3 and familial pancreatic carcinoma.